Patents by Inventor Michael Stekker

Michael Stekker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stent made of a bio-degradable magnesium alloy with a magnesium fluoride coating and an organic coating
    Patent number: 11793911
    Abstract: The present invention relates to stents made of a magnesium alloy degradable under physiological conditions having an inorganic coating comprising magnesium fluoride and having an organic coating. The stents according the invention can additionally be coated with at least one antiinflammatory, antiproliferative, antiangiogenic, antirestenotic, and/or antithrombogenic active agent.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: October 24, 2023
    Assignee: MeKo Laserstrahl-Materialbearbeitungen e.K.
    Inventors: Clemens Meyer-Kobbe, Michael Stekker, Roman Menze
  • STENT MADE OF A BIO-DEGRADABLE MAGNESIUM ALLOY WITH A MAGNESIUM FLUORIDE COATING AND AN ORGANIC COATING
    Publication number: 20200139017
    Abstract: The present invention relates to stents made of a magnesium alloy degradable under physiological conditions having an inorganic coating comprising magnesium fluoride and having an organic coating. The stents according the invention can additionally be coated with at least one antiinflammatory, antiproliferative, antiangiogenic, antirestenotic, and/or antithrombogenic active agent.
    Type: Application
    Filed: January 2, 2018
    Publication date: May 7, 2020
    Applicant: MeKo Laserstrahl-Materialbearbeitungen e.K.
    Inventors: Clemens Meyer-Kobbe, Michael Stekker, Roman Menze
  • Magnesium alloy and resorbable stents containing the same
    Patent number: 9566367
    Abstract: The present invention is directed to a magnesium alloy containing 5.0% by wt.-25.5% by wt. dysprosium, 0.01% by wt.-5.0% by wt. neodymium and/or europium, 0.1% by wt. 3.0% by wt. zinc, 0.1% by wt.-2.0% by wt. Zirconium, and balance to 100.0% by wt. magnesium, being degradable under physiological conditions and which is particularly suitable for the production of absorbable stents and to stents made thereof.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: February 14, 2017
    Assignees: Helmholtz-Zentrum Geesthacht Zentrum fur Material-und Kustenforschung GmbH, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K
    Inventors: Michael Stekker, Norbert Hort, Frank Feyerabend
  • Resorbable stents which contain a magnesium alloy
    Patent number: 9522219
    Abstract: The present invention is directed to stents made of a magnesium alloy degradable under physiological conditions and an outer polymeric coating. Herein, the stents according to the invention can be additionally coated with at least one anti-inflammatory, antiproliferative, antiangiogenic, antirestenotic and/or antithrombogenic active agent.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: December 20, 2016
    Assignees: HEMOTEQ AG, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K
    Inventors: Michael Stekker, Norbert Hort, Frank Feyerabend, Erika Hoffmann, Michael Hoffmann, Roland Horres
  • MAGNESIUM ALLOY AND RESORBABLE STENTS CONTAINING THE SAME
    Publication number: 20140222133
    Abstract: The present invention is directed to a magnesium alloy comprising dysprosium, being degradable under physiological conditions and which is particularly suitable for the production of absorbable stents and to stents made thereof.
    Type: Application
    Filed: August 15, 2012
    Publication date: August 7, 2014
    Applicants: Helmholtz-Zentrum Geesthacht Zentrum fur Material-und Kustenforschung GmbH, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K
    Inventors: Michael Stekker, Norbert Hort, Frank Feyerabend
  • RESORBABLE STENTS WHICH CONTAIN A MAGNESIUM ALLOY
    Publication number: 20140199365
    Abstract: The present invention is directed to stents made of a magnesium alloy degradable under physiological conditions and an outer polymeric coating. Herein, the stents according to the invention can be additionally coated with at least one anti-inflammatory, antiproliferative, antiangiogenic, antirestenotic and/or antithrombogenic active agent.
    Type: Application
    Filed: August 15, 2012
    Publication date: July 17, 2014
    Applicants: HEMOTEQ AG, MEKO LASERSTRAHL-MATERIALBEARBEITUNGEN E.K
    Inventors: Michael Stekker, Norbert Hort, Frank Feyerabend, Erika Hoffmann, Michael Hoffmann, Roland Horres